The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Post 7am (No RNS) rant about ‘Al’ being late. Classic Mortgage!!
In fairness, AS stated in his last interview that shareholders would be updated as each milestone in the process is achieved. Presumably one of these will be when the pilot batches have been manufactured? Then when clinical validation begins, like with BAMS?
@captainstanley
I was thinking along similar lines. In the latest directors talk interview, AS mentions all of the key milestones (pilot batches created etc) and infers that the market will be updated as each of these is met.
I guess this could have changed though. Especially if the government are involved, and want less transparency.
GUILTY
Agree MilkM0NSTA
Almost looks like they’re talking about a completely separate test that they’re developing? Very odd.
Fardistanthills - Lets hope they can be.
That would be one hell of an RNS :-) We can live in hope. Once again, thank you for the very detailed previous post.
Excellent info. Thank you, Fardistanthills.
In that case, it's not an option for Cytiva to have manufactured pilot batches of the completed product, and submitted them for EUA then, in your opinion?
Shame :-(
@R35Mike
Appreciate that. I am invested, albeit modestly. Love reading this board and have picked up some great info along the way.
@Richrob, I think that you’re one of the most informative posters on this board, and seem a genuinely nice person as well. I hope I haven’t made it to the green bin yet.
Apologies all. I genuinely didn’t intend to clog up the board with a childish spat. Just wanted clarification on a few points :-) I’ll pop back in my hole and make sure I attempt to discover the info for myself before asking a seeking such clarification again.
@Ophidian
Do your own research.
@Richrob
You ask if it’s Wednesday tomorrow? I’ll spoon feed you the answer, due to your laziness. Yes, it is.
You really should do your own research though, else Ophidian will have a pop :-)
@Ophidian
I’ve always had you down as a top poster, and appreciated you sharing your knowledge on this BB. Also questioned some posters attitude towards you. Now I fully understand it. You really are a condescending fool.
@Ophidian
Appreciate your answers. Very helpful.
I was merely after a bit of clarification from somebody like yourself. I'm not sure the condescending feel to your first sentence was entirely required, but there you go.
ATB
A few questions that i'm hoping somebody more knowledgeable than myself on such matters can help with:
1) Are Cytiva just our partner in the design and development of this test, or will they also be manufacturing at their facilities?
2) If the latter, is it feasible that they are or have already produced some pilot batches?
3) If they have, is it a possibility that these have already been submitted to the FDA for EUA? Or would this have needed to be RNS'd?
Thanks in advance for any help.
How many times, Global. You’re supposed to sell before it drops!! You really haven’t got the hang of this trading lark, have you? :-)
See my post below. It was included in an RNS in April that they were also working on a lab based test (pre BAMS)
From RNS 22/04/20
‘These Affimer reagents will be characterised by Avacta with the aim of developing a laboratory test for the SARS-COV-2 virus antigen within the next few weeks.’
Global, so you’re back in high, but will sell out when it drops (low) surely you can see the flaw in this, as a plan to make money? Jesus Christ.
Thank you, Global. Appreciate your honesty. Gonna be a sore one for you if the BIG RNS lands in the morning though, isn’t it? Dangerous game :-)
Global, just for fun, are you in or out currently?